IRIS
GIACOMETTI, Andrea
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.253
EU - Europa 6.812
AS - Asia 3.288
SA - Sud America 363
AF - Africa 204
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 9
Totale 21.941
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.178
UA - Ucraina 1.462
SG - Singapore 1.115
IE - Irlanda 825
RU - Federazione Russa 803
IT - Italia 792
SE - Svezia 784
TR - Turchia 692
DE - Germania 685
CN - Cina 546
DK - Danimarca 532
HK - Hong Kong 517
FI - Finlandia 341
BR - Brasile 335
KR - Corea 287
FR - Francia 270
GB - Regno Unito 182
CI - Costa d'Avorio 163
IN - India 40
CA - Canada 37
MX - Messico 28
IR - Iran 27
BE - Belgio 25
MA - Marocco 25
NL - Olanda 25
AT - Austria 19
RO - Romania 15
EU - Europa 11
IQ - Iraq 10
PL - Polonia 10
RS - Serbia 10
AR - Argentina 9
JP - Giappone 8
CH - Svizzera 7
AU - Australia 6
BD - Bangladesh 6
CO - Colombia 6
PK - Pakistan 6
BG - Bulgaria 5
CL - Cile 5
OM - Oman 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
EC - Ecuador 3
ES - Italia 3
HR - Croazia 3
KE - Kenya 3
KZ - Kazakistan 3
MY - Malesia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
PY - Paraguay 3
UZ - Uzbekistan 3
CM - Camerun 2
CY - Cipro 2
DZ - Algeria 2
HN - Honduras 2
LT - Lituania 2
NP - Nepal 2
TN - Tunisia 2
VE - Venezuela 2
VN - Vietnam 2
A1 - Anonimo 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
CG - Congo 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IS - Islanda 1
JO - Giordania 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 21.941
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.488
Chandler 1.169
Fairfield 1.124
Dublin 815
Boardman 748
Ashburn 594
Wilmington 585
Singapore 539
Hong Kong 509
Woodbridge 486
Seattle 399
Houston 386
New York 373
Ann Arbor 368
Des Moines 339
Cambridge 334
Lawrence 316
Princeton 316
San Mateo 312
Moscow 235
Abidjan 163
San Diego 142
Centro 135
Turin 115
Beijing 86
Redmond 67
The Dalles 67
Guangzhou 47
Shanghai 45
Norwalk 43
London 42
Los Angeles 42
Izmir 40
Ancona 38
Turku 36
Munich 34
Helsinki 31
Porto 28
Wuhan 28
Washington 27
Brussels 25
Pune 25
Nuremberg 22
Falls Church 21
São Paulo 21
Ottawa 19
Wuxi 19
Dallas 18
Rome 18
Marche 17
Mexico City 16
Kilburn 15
Civitanova Marche 14
Jiaxing 14
Nanjing 13
Cingoli 12
Istia D'ombrone 11
Prescot 10
Saint Louis 10
Belgrade 9
Belo Horizonte 9
North Bergen 9
Shenzhen 9
Brasília 8
Dronten 8
Rio de Janeiro 8
Seoul 8
Vienna 8
Buffalo 7
Campinas 7
Chiswick 7
Fort Worth 7
Hounslow 7
Santa Clara 7
Yiwu 7
Auburn Hills 6
Curitiba 6
Fayetteville 6
Mcallen 6
Pergola 6
Pesaro 6
Phoenix 6
Stockholm 6
Toronto 6
Acton 5
Amsterdam 5
Atlanta 5
Baghdad 5
Falconara Marittima 5
Hanover 5
Jesi 5
Montreal 5
Perugia 5
San Benedetto del Tronto 5
Tolentino 5
Boston 4
Boydton 4
Brooklyn 4
Campobasso 4
Castelfiorentino 4
Totale 13.265
Salva come PNG Salva come JPEG
Nome #
Comparative efficacy of topical versus systemic teicoplanin in experimental model of wound infections 269
Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides 218
RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 190
Antimicrobial Resistance: A Challenge for the Future 181
Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection. 147
BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci. 138
Enhanced efficacy of combinations of pexiganan with colistin versus Acinetobacter baumannii in experimental sepsis 123
Efficacy of the quorum sensing inhibitor FS10 alone and in combination with tigecycline in an animal model of staphylococcal infected wound 121
Colistin enhances therapeutic efficacy of daptomycin or teicoplanin in a murine model of multiresistant Acinetobacter baumannii sepsis. 120
Anticryptosporidial activity of paromomycin. 117
Protective effects of the combination alpha-helical antimicrobial peptides and rifampin in three rat models of Pseudomonas aeruginosa infection 116
Activity of nitazoxanide alone and in combination with azithromycin and rifabutin against Cryptosporidium parvum in cell culture. 110
CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: An observational cohort study 108
Antimicrobial activity of polycationic peptides 106
Tachyplesin III and Granulocyte-Colony Stimulating Factor Enhance the Efficacy of Piperacillin/Tazobactam in a Neutropenic Mouse Model of Polymicrobial Peritonitis 105
Tigecycline accelerates staphylococcal infected burn wound helaing through MMP-9 modlualtion 103
SARS-CoV-2 infection in kidney transplant recipients: Experience of the italian marche region 103
Cecropin B enhances betalactams activities in experimental rat models of gram-negative septic shock 102
Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds. 101
In-vitro effect of short-term exposure to two synthetic peptides, alone or in combination with clarithromycin or rifabutin, on Cryptosporidium parvum infectivity. 99
In vitro activity and in vivo animal model efficacy of IB-367 alone and in combination with imipenem and colistin against Gram-negative bacteria. 99
Activity of buforin II alone and in combination with azithromycin and minocycline against Cryptosporidium parvum in cell culture. 98
In-vitro activity of the synthetic protegrin IB-367 alone and in combination with antifungal agents against clinical isolates of Candida spp. 98
Tocilizumab in COVID-19 interstitial pneumonia 98
Effects of the Infusion of 4% or 20% Human Serum Albumin on the Skeletal Muscle Microcirculation in Endotoxemic Rats 95
First-line antiretroviral therapy with efavirenz plus tenofovir disiproxil fumarate/emtricitabine or rilpivirine plus tenofovir disiproxil fumarate/emtricitabine: a durability comparison 95
An (Italian) proposal for a comprehensive approach to infections across the surgical pathway 95
High rate of ceftobiprole resistance among clinical methicillin-resistant Staphylococcus aureus isolates from a hospital in central Italy 94
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: The D:A:D study 93
Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis 92
Efficacy of pexiganan combination with tigecycline in a mouse model of Pseudomonas aeruginosa sepsis 92
In vitro activity of Protegrin-1, alone and in combination with clinically useful antibiotics, against Acinetobacter baumannii strains isolated from surgical wounds 92
Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study 91
Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. 91
Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus. 90
Efficacy of Tigecycline and Rifampin Alone and in Combination against Enterococcus faecalis Biofilm Infection in a Rat Model of Ureteral Stent. 90
In vitro activity and in vivo efficacy of tigecycline alone and in combination with daptomycin and rifampin against Gram-positive cocci isolated from surgical wound infection. 90
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 90
Suppression of biofilm related, device-associated infections by staphylococcal quorum sensing inhibitors. 89
The Antimicrobial Peptide Tachyplesin III Coated alone and in Combination with Intraperitoneal Piperacillin-Tazobactam Prevents Ureteral Stent Biofilm Formation in a Rat Subcutaneous Pouch Model of Pseudomonas Infection. 89
Epidemiology and microbiology of surgical wound infections. 89
ACTIVITY OF THE NEW ANTIFUNGAL TRIAZOLE, POSACONAZOLE, AGAINST CRYPTOCOCCUS NEOFORMANS 88
Antiendotoxin activity of antimicrobial peptides and glycopeptides. 88
Synergistic effect of antimicrobial peptide LL-37 and colistin combination against multidrug-resistant Escherichia coli isolates 88
In-vitro activity of rifabutin and albendazolo singly and in combination with other clinically used antimicrobial agents against Pneumocystis carinii. 87
Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats. 87
The antimicrobial peptide Tachyplesin III coated alone and in combination with intraperitoneal piperacillin-tazobactam prevents ureteral stent Pseudomonas infection in a rat subcutaneous pouch model 86
Therapeutic efficacy of the magainin analogue MSI-78 in different intra-abdominal sepsis rat models. 86
Urinary catheters and biofilm formation 86
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): A multicohort collaboration 86
In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Grampositive cocci isolated from surgical wound infections 86
Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock 85
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitors 85
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. 84
Incidence and factors associated with the risk of sexually transmitted diseases in HIV-infected people seen for care in Italy: Data from the Icona Foundation cohort 84
Tollerabilità metabolica e durevolezza degli schemi antiretrovirali comprendenti nevirapina (Durability and tolerability of long-term nevirapine-based HAART). 83
Daptomycin and Rifampin Alone and in Combination Prevent Vascular Graft Biofilm Formation and Emergence of Antibiotic Resistance in a Subcutaneous Rat Pouch Model of Staphylococcal Infection. 83
Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin 83
The antimicrobial peptide BMAP-28 reduces lethality in mouse models of staphylococcal sepsis 83
Efficacy and tolerability of switching to a dual therapy with darunavir/ritonavir plus raltegravir in HIV-infected patients with HIV-1 RNA ≤50cp/mL. 83
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 83
Long-term data on the efficacy and tolerability of lamivudine plus dolutegravir as a switch strategy in a multi-centre cohort of HIV-1-infected, virologically suppressed patients 83
Quorum Sensing Inhibitor FS3-coated Vascular Graft Enhances Daptomycin Efficacy in a Rat Model of Staphylococcal Biofilm Infection. 83
OpuC--an ABC transporter that is associated with Staphylococcus aureus pathogenesis. 82
Effect of the combination of clarithromycin and amikacin on Pseudomonas aeruginosa biofilm in a animal model of ureteral stent infection. 82
Amphibian Peptides Prevent Endotoxemia and Bacterial Translocation in Bile Duct-Ligated Rats 82
Temporin A alone and in combination with imipenem reduces lethality in a mouse model of staphylococcal sepsis. 82
Incidence and progression to cirrhosis of new hepatitis C virus infections in persons living with human immunodeficiency virus. 82
In vitro activity of the synthetic lipopeptide PAL-Lys-Lys-NH(2) alone and in combination with antifungal agents against clinical isolates of Cryptococcus neoformans. 81
BMAP-28 improves the efficacy of vancomycin in rat models of gram-positive cocci ureteral stent infection 81
Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. 81
IB-367 pre-treatment improves the in vivo efficacy of teicoplanin and daptomycin in an animal model of wounds infected with meticillin-resistant Staphylococcus aureus 81
whISOBAX™ inhibits bacterial pathogenesis and enhances the effect of antibiotics 81
In vitro activity of amphibian peptides alone and in combination with antimicrobial agents against multidrug-resistant pathogens isolated from surgical wound infection. 80
In vitro activities of tritrpticin alone and in combination with other antimicrobial agents against Pseudomonas aeruginosa. 80
In vitro and in vivo activity of aurintricarboxylic acid preparations against Cryptosporidium parvum. 80
Role of daptomycin on burn wound healing in an animal methicillin-resistant staphylococcus aureus infection model 80
Clinical and epidemiological characteristics of KPC-producing Klebsiella pneumoniae from bloodstream infections in a tertiary referral center in Italy 80
Vitamin E supplementation in old mice induces antimicrobial activity and improves the efficacy of daptomycin in an animal model of wounds infected with methicillin resistant Staphylococcus aureus. 79
In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients. 79
Antiendotoxin activity of protegrin analog IB-367 alone or in combination with piperacillin in different animal models of septic shock 79
Active HCV Replication but Not HCV or CMV Seropositive Status Is Associated with Incident and Prevalent Type 2 Diabetes in Persons Living with HIV. 79
Delayed wound healing in aged skin rat models after thermal injury is associated with an increased MMP-9, K6 and CD44 expression 79
Viscoelastic behaviour of hyaluronic acid formulations containing carvacrol prodrugs with antibacterial properties 79
Efficacy of tachyplesin III, colistin, and imipenem against a multiresistant Pseudomonas aeruginosa strain. 78
Lipopeptide Laur-CKK-NH2 dimer preserves daptomycin susceptibility and enhances its activity against Enterococcus faecalis. 78
New evidence and insights on dalbavancin and wound healing in a mouse model of skin infection 78
Pre-treatment of central venous catheters with the cathelicidin BMAP-28 enhances the efficacy of antistaphylococcal agents in the treatment of experimental catheter-related infection. 77
RNAIII-Inhibiting Peptide-Loaded Polymethylmethacrylate Prevents In Vivo Staphylococcus aureus Biofilm Formation 76
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 76
In vitro activity and killing effect of the synthetic hybrid cecropin A-melittin peptide CA(1-7)M(2-9)NH(2) on methicillin-resistant nosocomial isolates of Staphylococcus aureus and interactions with clinically used antibiotics. 76
Cationic peptides combined with betalactams reduce mortality from peritonitis in experimental rat model. 76
Antiseptic compounds still active against bacterial strains isolated from surgical wound infections despite increasing antibiotic resistance. 76
Effects of pexiganan alone and combined with betalactams in experimental endotoxic shock 76
Efficacy of quinupristin/dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. 76
S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. 76
Anticryptosporidial activity of ranalexin, lasalocid and azithromycin alone and in combination in cell lines. 76
Use of dalbavancin in skin, bone and joint infections: A real-life experience in an Italian center 76
Psoriasi e AIDS. A proposito di un caso. 75
Protective effects of the combination of alpha-helical antimicrobial peptides and rifampicin in three rat models of Pseudomonas aeruginosa infection. 75
Totale 9.407
Salva come PNG Salva come JPEG
Categoria #
all - tutte 124.227
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 124.227
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020482 0 0 0 0 0 0 0 0 0 0 52 430
2020/20214.597 246 475 611 62 500 297 433 304 475 482 479 233
2021/20222.533 215 546 25 124 34 174 125 150 167 299 195 479
2022/20233.964 417 371 296 273 284 626 7 206 1.030 20 307 127
2023/20242.307 433 47 138 383 408 471 34 63 21 26 37 246
2024/20254.270 653 421 290 131 165 239 451 191 1.109 304 316 0
Totale 22.367